Aptar Pharma acquires SipNose's nasal drug delivery assets for $12.5M

US drug delivery company Aptar Pharma acquired the device technology assets of Israeli company SipNose Nasal Delivery Systems for approximately $12.5 million. SipNose, based in Yokneam, has developed a nasal drug delivery system for precise targeting of the nasal cavity.

“This method is able to penetrate the Blood Brain Barrier through a breach discovered 20 years ago.”en.globes.co.il

• 1 source
• en.globes.co.ilAptar Pharma buys Israeli drug delivery co SipNose - GlobesGali WeinrebOct 10, 2024

Summarized from public sources; check the original articles before acting on it.